Objective. The main objective of this study is to determine if epicardial fat thickness can be an early marker of insulin resistance. The specific objectives are to determine the specific thickness of epicardial fat that will correlate with insulin resistance and to correlate epicardial fat thickness with co-morbidities, anthropometric measurements and other clinical variables.
INTRODUCTION
Insulin resistance is a growing problem and is a state in which a given concentration of insulin produces a lessthan-expected biological effect. Insulin resistance has also been arbitrarily defined as the requirement of 200 or more units of insulin per day to attain glycemic control and to prevent ketosis. 1 Several diseases and syndromes such as type 2 diabetes mellitus and metabolic syndrome are associated with insulin resistance.
Metabolic Syndrome is a state of insulin-resistance that has been known by many names: Syndrome X, Deadly Quartet or the Dysmetabolic Syndrome has drawn the greatest attention because of its public health importance. It is defined by the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) guidelines and included the presence of at least three criteria among the following: waist circumference at least 102 cm for men and at least 88 cm for women; triglyceride level of 150 mg/dL or higher; HDL-C level of less than 40 mg/dL in men or less than 50 mg/dL in women; blood pressure of 130/85 mm Hg or higher; fasting glucose level of >100 mg/dL. 2 Due to the great risk of developing complications from insulin resistance, early detection and intervention are important to prevent the morbidity and mortality associated with these complications.
The gold standard for determining insulin resistance is to use the hyperinsulinemic-euglycemic clamp. This technique provides for a direct measure of glucose uptake under insulin-stimulated conditions. Given the complicated nature and potential hypoglycemic effect of the procedure, the Homeostatic Model Assessment (HOMA) is considered an alternative method which is a simple and easy method to determine the presence of insulin resistance. 13 The formula of HOMA-IR is fasting blood sugar (mmol/ml) x insulin assay (microunits/ml)/22.5. 13 Several studies have shown that epicardial fat thickness has a positive correlation with insulin resistance. [2] [3] [4] [5] Since e-ISSN 2308-118X the hyperinsulinemic-euglycemic clamp technique is tedious and carried out only in research laboratories and because insulin assays are expensive, this paper seeks to investigate whether epicardial fat thickness measurement through routine 2D echocardiogram can be a diagnostic tool for predicting insulin resistance.
OBJECTIVES
The general objective is to determine if epicardial fat thickness can be an early marker of insulin resistance.
Specific objectives are: 1) to determine the specific thickness of epicardial fat that will correlate with insulin resistance and 2) to correlate epicardial fat thickness with co-morbidities, anthropometric measures, fatty liver infiltration abdominal ultrasound and other clinical variables.
METHODOLOGY

A. Study Design and Setting
The study used a cross-sectional design among subjects undergoing in and out patient executive check-ups at the Cardinal Santos Medical Center from August to September 2010. Letters were sent out to doctors for recruitment of subjects. The initial result consisted of a total of 35 subjects who underwent inpatient or outpatient executive check-up. Subjects were prospectively recruited using a non-probability, purposive, prospective sampling. Baseline clinical data and blood samples were collected. Insulin resistance was measured using the HOMA-IR equation. Epicardial fat thickness was measured through 2D echocardiogram (Appendix A).
B. Subject Selection
The patients included in this study met all of the following inclusion criteria and did not fulfill the exclusion criteria listed below:
A Anthropometric measurements were collated. Weight in kilograms and height in centimeters were measured. BMI (kg/m 2 ) was calculated. Waist circumference, the minimum circumference, located between the lower rib margin and the iliac crest or midwaist and hip circumference, over the greater trochanters were measured. Hip to waist ratio was computed. The researchers did all measurements.
Epicardial fat thickness was measured using GE VIVID 7 (high resolution) 2D echocardiogram. Free wall of the right ventricle from both parasternal-long and short-axis and subcostal region views were chosen for measurement of epicardial fat thickness for two reasons: 1) this point is recognized as the highest absolute epicardial fat layer thickness; and 2) parasternal long-and short-axis views allow the most accurate measurement of adipose tissue on right ventricle, with optimal cursor beam orientation in each view. 4, 6, 10 Epicardial fat thickness is best measured at end-systole because it is compressed during diastole. Epicardial fat thickness was measured by a single reader.
The subject was fasted for 12 hours prior to taking the blood sample for FBS using hexokinase, lipid profile using the Dade assay and fasting insulin level using enzyme immunoassay. Blood samples were stored at 0.2-0.8 0 C temperature and were brought to Asiatic Laboratories for analysis. Fatty liver infiltration was checked using LOGIC 7 GE (high resolution) ultrasound. Abdominal ultrasound was viewed and measured by a single reader. The HOMA is a reliable marker for measuring insulin resistance among patients with or without diabetes mellitus. This has been proven by the studies of Lansang 8 and Bonora. 13 Both researchers compared HOMA with the glucose clamp technique and concluded that HOMA can be a less tedious and less expensive alternative for measuring insulin resistance. Based on the Bruneck Study, a HOMA-IR value of 2.77 was chosen as the threshold for insulin resistance. 13 Low HOMA-IR values indicate a high insulin sensitivity, whereas high HOMA-IR values indicate a low insulin sensitivity (insulin resistance).
D. Statistical Analysis
SPSS software package version 19 and EPI info version 3.5.1. were used for statistical analysis. Correlation analysis was performed by the Pearson test. Linear regression analysis was performed on all anthropometric, co-morbidities and clinical variables to identify correlates with epicardial fat thickness.
Correlation Coefficient was computed to see the degree of association of patient characteristics, clinical variables and HOMA-IR with epicardial fat thickness.
Spearman's rho was used to test the correlation between epicardial fat thickness and HOMA-IR.
RESULTS
A total of 35 subjects was recruited for the study. However, 11 subjects did not have fasting insulin levels and 2 subjects did not have 2D echo result. A total of 22 subjects was included in the study. Five subjects were considered overweight and 6 subjects were considered obese based on their BMI and waist to hip ratio using the WHO criteria and definition. Based on the data, 36% of the study population, had insulin resistance. Of the 10 previously known diabetics, 60% had insulin resistance. Table 1 shows the demographic characteristics of the subjects. The mean age of the subjects is 57.31 (SD=13.63) and there is male preponderance (72.7% ; n=16). Mean BMI 26.16 (SD=4.81) and is above the normal range based on WHO criteria. Mean HOMA 2.77 (SD=1.87) and mean epicardial fat thickness of 9.03 (SD=4.47) were found to be within normal range. Only 18.2% (n=4) had fatty infiltration of the liver based on their abdominal ultrasound. Prevalence of insulin resistance in these subjects was 45.5%, using the NCEP ATP III criteria. Of the 10 subjects who had both hypertension and diabetes mellitus, 6 or 60% had insulin resistance.
To check for factors associated with increased epicardial fat thickness, correlation coefficients were computed and is summarized in Table 2 . Among the factors, age (r = 0.00, p-value 0.95), gender (correlation coefficient 0.01, p-value 0.63), hypertension (r = 0.00, p-value 0.89), diabetes mellitus (r = 0.09, p-value 0.17), Cerebrovascular accident (CVA) (r = 0.09, p-value 0.17), Coronary artery disease (CAD)/Ischemic heart disease (IHD) (r = 0.05, p-value 0.32), hypercholesterolemia (r = 0.01, p-value 0.70), waist to hip ratio (r = 0.04, p-value 0.37), presence of fatty liver thru abdominal ultrasound (r = 0.00, p-value 0.89), FBS (r = 0.20, p-value 0.37) were not significantly correlated to epicardial fat thickness. (Table 3) . Based on the analysis, 9.5 mm had the highest sensitivity and specificity, 100% and 86% respectively (Table 4) . Area under curve (AUC) was 0.893 with 95% confidence interval of 0.746 to 1.040 (Table 5 ). 0.000 0.000 Based on the analysis, 9.5mm was noted to be with the highest sensitivity and specificity, 100% and 86% respectively. In the research done by Iacobellis, 14 , the study also proposed 9.5 mm as a cut-off of epicardial fat thickness for determining presence of insulin resistance.
Using the Spearman's rho, there is a significant correlation between HOMA-IR cut off of 2.77 and epicardial fat thickness cut off of 9.5mm as shown in Table 6 . Figure 1 shows the sensitivity and specificity of epicardial fat thickness in predicting the presence of insulin resistance while figure 2 shows the positive correlation between echocardiographic epicardial fat thickness and HOMA-IR. 
DISCUSSION
Insulin resistance is an emerging problem, necessitating prompt treatment. HOMA-IR is the diagnostic of choice for determining the presence of insulin resistance. However, insulin assay is expensive and tedious, requiring a 12 hour fast before blood extraction. Epicardial fat thickness has been associated with insulin resistance.
Hence, measurement of epicardial fat thickness through routine 2D echocardiogram can be an alternative diagnostic test for diagnosing insulin resistance, since it is cheaper, less tedious and more available compared to insulin assay.
Our results showed that epicardial fat thickness is correlated with insulin resistance using HOMA-IR. A similar study by Aydin, 2 showed that epicardial fat thickness correlated with several factors including HOMA-IR. Epicardial fat thickness threshold of  9.5mm was noted to be correlated with insulin resistance. A similar study by Iacobellis, 6 proposed that  9.5 mm epicardial fat thickness be the cut-off value for diagnosing metabolic syndrome, increased abdominal fat and insulin resistance, while 11mm be the cut-off for high insulin resistance.
Several studies show that obesity is associated with insulin resistance. 4, 15 Anthropometric measurements are widely used, but are frequently imprecise. Although waist circumference is widely accepted as a good predictor of intraabdominal fat mass, imaging techniques are more precise and reliable. 10 Magnetic Resonance imaging is the gold standard for measuring visceral adipose fat but is expensive.
Hence, this study proposes routine 2D echocardiogram with the measurement of the parasternal long-and shortaxis view and subcostal regions to be an alternative method for measuring epicardial adipose tissue thickness.
Using the correlation coefficient, BMI was noted to be significantly correlated with epicardial fat thickness as shown in Table 2 . The study by Iacobellis, 4 showed that epicardial fat is significantly related to obesity-related insulin resistance. Obesity is frequently associated with insulin resistance and abnormalities in glucose metabolism. Although visceral fat in the trunk is known to be correlated with insulin resistance in both diabetic and non-diabetic subjects, extra-abdominal fat depots including mediastinal and epicardial adipose tissues, have only recently been considered. 4 Another variable which was found to be significantly correlated to epicardial fat thickness was fasting insulin level. Studies done by Iacobellis 4 and Hizli 15 showed that fasting insulin level was one of the factors that was significantly correlated to epicardial fat thickness. Both papers included obese subjects.
CONCLUSION
The 2D Echocardiogram can be used as an early marker of insulin resistance. The computed threshold for epicardial fat thickness of 9.5mm, which is significantly correlated to HOMA-IR, can be used as a cut-off for predicting presence of insulin resistance.
Limitations
The limitations of the study include a small sample size primarily due to financial limitations.
Recommendations
The authors recommend that the study be extended to include more subjects to increase the power. Nonetheless, based on the result of this research paper, the authors recommend the measurement of epicardial fat thickness at the free wall of the right ventricle from both parasternal long and short-axis and subcostal regions in all routine 2D echocardiogram evaluations, with a cut-off value of 9.5 mm for early detection of insulin resistance. It is noninvasive, less tedious and a relatively inexpensive method to identify at risk individuals for insulin resistance.
